
5-Year ILLUMENATE EU RCT and Pivotal Study Results Confirm Safety Profile of Philips Stellarex .035” Low-dose Drug-coated Balloon
The ILLUMENATE EU RCT and ILLUMENATE Pivotal RCT together comprised approximately 600 patients in Europe and the U.S.
View the latest clinical trials, studies, data, and updates.
The ILLUMENATE EU RCT and ILLUMENATE Pivotal RCT together comprised approximately 600 patients in Europe and the U.S.
Acta Medica Okayama, researchers at Okayama University describe an innovative plate that confines patients to their beds while undergoing vascular procedures thereby preventing unforeseen falls.
The study, called BENEFIT, evaluated the safety and feasibility of the MONARCH Platform, a first-of-its-kind robotic technology indicated for use in diagnostic and therapeutic bronchoscopic procedures. Results of the study were published in CHEST, the official publication of the American College of Chest Physicians.
ADAPT-PD (Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease) trial (first patient enrolled) evaluating the safety and efficacy of adaptive deep brain stimulation (aDBS)
The clinical trial is planned to recruit an additional 22 patients and aims to establish the validity of the Campbell Score™ as an objective marker to quantify the risk of suicide.
“This important study establishes the clinical and economic advantages that our DiskCover System delivers over the use of disposable stethoscopes,” said Scott Mader, CEO and co-founder of AseptiScope.